Member Log In

HEALTH INNOVATION STARTUP RESBIOTECH SPINS OUT OF UAB

24 Nov 2020 9:00 AM | Anonymous member (Administrator)

A University of Alabama at Birmingham (UAB) faculty member has founded a company to tackle the pervasive problems faced with respiratory diseases.

ResBiotech, a cardio-respiratory health innovation platform company, was recently launched by Dr. Charitharth Vivek Lal to target respiratory diseases like chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma and others. Affecting more than 20 million people in the United States alone, respiratory diseases represent a $50 billion market and show no signs of decreasing.

ResBiotech, which was launched with UAB’s Bill L. Harbert Institute for Innovation and Entrepreneurship and is working with the Birmingham Business Alliance (BBA) and other partners to seek investors, will revolutionize the future of patient care and strengthen Birmingham’s health care and entrepreneurial ecosystems, said Jon Nugent, vice president of innovation and technology for the BBA.

“Birmingham is the right place to launch this type of company because of the continual health care innovation that is one of our region’s trademarks,” said Nugent, who has worked with Dr. Lal for over a year. “There is continued and widespread interest in state-of-the-art health care innovation. Dr. Lal’s vision, coupled with support from UAB and local stakeholders, could prove to be pathbreaking for Birmingham and Alabama as a whole.”

Using medical technologies to solve major health challenges, its first product, ResBiotic – currently in preclinical development – will serve as a wellness supplement for respiratory illnesses in people of all ages.

“The company will be focused on the invention, creation and monetization of proprietary medical technologies that solve major health challenges,” Lal said.

Dr. Sanjay Singh, a local entrepreneur, former UAB faculty and a member of the BBA’s Executive Committee, will serve as the strategic business adviser for ResBiotech. In addition, a Scientific Advisory Board will be created for the company.

“ResBiotech will be an innovation, investment and commercialization vehicle, with access to world-class researchers and facilities locally,” said Singh. “I foresee ResBiotech positioned to become a national leader in the cardio-respiratory innovation industry, one that could revolutionize patient care in the future.”

Dr. Kathy Nugent, executive director of the Bill L. Harbert Institute for Innovation and Entrepreneurship at UAB, emphasized Birmingham’s entrepreneurial ecosystem and Dr. Lal’s board service to Urgent Care for Children, another Birmingham startup that is quickly growing.

“It’s exciting to see research born in the university spin out and grow in Birmingham, as our ecosystem is poised for cultivating innovative concepts,” said Nugent.  

Click here to learn more.


Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
Post Office Box 13906
Birmingham, AL 35202

administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software